Clinical trials

  • PANITUMUMAB for Metastatic colorectal cancer | RAS and BRAF wild-type metastatic colorectal cancer
  • Edoxaban for Porto-sinusoidal vascular disorder
  • Permethrin for Scabies
  • NORFLOXACIN for Portal hypertension | Decompensated cirrhosis
  • KO-2806 for Pancreatic ductal adenocarcinoma | Colorectal cancer | Non-small cell lung cancer | Renal cell carcinoma
  • AUTOLOGOUS T-CELLS TRANSDUCED WITH LENTIVIRAL VECTOR EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD19 for Relapsed or refractory CD19-positive B-cell malignancies | Acute lymphoblastic leukemia (B-ALL) | Non-Hodgkin lymphoma | Chronic lymphocytic leukemia
  • REMIBRUTINIB for Hidradenitis suppurativa (moderate to severe)
  • Amoxicillin; Clavulanic acid for Ventilator-associated pneumonia | Intensive care
  • DKY709 for Nasopharyngeal carcinoma|Triple-negative breast cancer|Microsatellite stable colorectal cancer|Non-small cell lung cancer|Cutaneous melanoma
  • RIPRETINIB for Advanced gastrointestinal stromal tumour | Gastrointestinal stromal tumour
  • REMIBRUTINIB for Hidradenitis suppurativa
  • [AL[18F]F]FAPI-74 for Advanced gastric cancer